156 related articles for article (PubMed ID: 38474177)
61. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
62. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
63. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
64. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
65. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
66. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
67. LANA regulates miR-155/GATA3 signaling axis by enhancing c-Jun/c-Fos interaction to promote the proliferation and migration of KSHV-infected cells.
Luo T; Pan Y; Liu Y; Zheng J; Zhuang Z; Ren Z; Zhu J; Gu Y; Zeng Y
J Med Virol; 2023 Jan; 95(1):e28255. PubMed ID: 36284455
[TBL] [Abstract][Full Text] [Related]
68. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
69. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
70. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
71. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
[TBL] [Abstract][Full Text] [Related]
72. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
[TBL] [Abstract][Full Text] [Related]
73. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
Hwang LR; Cha S; Jong JE; Jang JH; Seo T
Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
[TBL] [Abstract][Full Text] [Related]
74. The expression profiles of microRNAs in Kaposi's sarcoma.
Wu XJ; Pu XM; Zhao ZF; Zhao YN; Kang XJ; Wu WD; Zou YM; Wu CY; Qu YY; Zhang DZ; Feng YY; Liu JY
Tumour Biol; 2015 Jan; 36(1):437-46. PubMed ID: 25266797
[TBL] [Abstract][Full Text] [Related]
75. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
76. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
77. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
78. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
[TBL] [Abstract][Full Text] [Related]
79. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
80. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
